Last Price
342.41
Today's Change
+5.94 (1.76%)
Day's Change
334.01 - 347.58
Trading Volume
373,138
Market Cap
10 Billion
Shares Outstanding
31 Million
Avg Volume
285,483
Avg Price (50 Days)
343.74
Avg Price (200 Days)
365.87
PE Ratio
27.13
EPS
12.62
Earnings Announcement
21-Apr-2025
Previous Close
336.47
Open
337.33
Day's Range
334.013 - 347.58
Year Range
302.01 - 459.77
Trading Volume
373,138
1 Day Change
1.77%
5 Day Change
-5.97%
1 Month Change
3.48%
3 Month Change
2.26%
6 Month Change
-11.11%
Ytd Change
2.29%
1 Year Change
-12.16%
3 Year Change
96.53%
5 Year Change
249.90%
10 Year Change
1132.13%
Max Change
1132.13%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.